Prometheus Biosciences Inc (RXDX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
for [[ item.sessionDateDisplayLong ]]
Results
download Want to compare other data? Select Fields| Symbol | RXDX | EXEL | ITCI | ||
| Company | Prometheus Biosciences Inc | Exelixis Inc | Intra-Cellular Ther | ||
| Price Information | |||||
| Exchange | NASDAQ | NASDAQ | NASDAQ | ||
| Open | 199.68 | 34.25 | 86.53 | ||
| High | 199.98 | 35.56 | 98.40 | ||
| Low | 199.60 | 34.10 | 86.25 | ||
| Last | 199.92 | 35.39 | 94.48 | ||
| Change | +0.18 | +0.89 | +11.92 | ||
| % Change | +0.09% | +2.58% | +14.44% | ||
| Volume | 1,860,600 | 1,061,154 | 2,639,933 | ||
| 20-Day Average Volume | 1,174,595 | 1,995,191 | 622,037 | ||
| Previous Close | 199.74 | 34.50 | 82.56 | ||
| Industry | Medical - Biomedical | Medical - Biomedical | Medical - Biomedical | ||
| Has Options | No | Yes | Yes | ||
| Technicals | |||||
| 20-Day Moving Average | 198.02 | 34.23 | 84.67 | ||
| 20-Day Raw Stochastic | 99.23% | 78.83% | 75.27% | ||
| 20-Day Relative Strength | 81.45% | 58.86% | 66.33% | ||
| Weighted Alpha | +110.70 | +63.83 | +48.37 | ||
| Today's Opinion | 100% Buy | 80% Buy | 80% Buy | ||
| Previous Opinion | 100% Buy | 56% Buy | 40% Buy | ||
| Last Month's Opinion | 88% Buy | 88% Buy | 88% Buy | ||
| Performance | |||||
| 5-Days | |||||
| %Chg | +0.47% since 06/08/23 | +4.73% since 01/02/25 | +11.65% since 01/02/25 | ||
| Low | 198.91 on 06/09/23 | 33.05 on 01/06/25 | 80.82 on 01/07/25 | ||
| High | 199.98 on 06/15/23 | 35.56 on 01/10/25 | 98.39 on 01/10/25 | ||
| 1-Month | |||||
| %Chg | +2.82% since 05/15/23 | +0.89% since 12/10/24 | +13.16% since 12/10/24 | ||
| Low | 189.76 on 05/16/23 | 33.05 on 01/06/25 | 80.82 on 01/07/25 | ||
| High | 199.98 on 06/15/23 | 36.22 on 12/16/24 | 98.39 on 01/10/25 | ||
| 3-Month | |||||
| %Chg | +72.97% since 03/15/23 | +38.25% since 10/10/24 | +27.77% since 10/10/24 | ||
| Low | 104.55 on 03/30/23 | 25.76 on 10/11/24 | 73.70 on 10/11/24 | ||
| High | 199.98 on 06/15/23 | 36.97 on 11/29/24 | 98.39 on 01/10/25 | ||
| 6-Month | |||||
| %Chg | +85.68% since 12/15/22 | +61.20% since 07/10/24 | +21.68% since 07/10/24 | ||
| Low | 103.33 on 01/06/23 | 22.13 on 07/11/24 | 70.90 on 10/07/24 | ||
| High | 199.98 on 06/15/23 | 36.97 on 11/29/24 | 98.39 on 01/10/25 | ||
| Key Statistics | |||||
| Market Capitalization, $K | 9,558,772 | 9,852,476 | 8,752,762 | ||
| Shares Outstanding, K | 47,813 | 285,579 | 106,017 | ||
| Annual Sales | 6,810,000 | 1,830,210,000 | 464,370,000 | ||
| Annual Net Income | -141,750,000 | 207,770,000 | -139,670,000 | ||
| Last Quarter Sales | 1,110,000 | 539,540,000 | 175,380,000 | ||
| Last Quarter Net Income | -40,880,000 | 117,970,000 | -26,320,000 | ||
| 60-Month Beta | -0.49 | 0.53 | 0.70 | ||
| Per-Share Information | |||||
| Most Recent Earnings | -0.86 on 05/09/23 | 0.47 on 10/29/24 | -0.25 on 10/30/24 | ||
| Latest Earnings Date | 08/10/23 | 02/04/25 | 02/27/25 | ||
| Most Recent Dividend | N/A | N/A | N/A | ||
| Next Ex-Dividends Date | N/A | N/A | N/A | ||
| Ratios | |||||
| Price/Earnings ttm | 0.00 | 22.21 | 0.00 | ||